Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )
This study has been terminated.
( Failure to recruit patients with membranous lupus nephritis not previously treated with azathioprine . )
Study NCT00368264 Information provided by Medical University of Vienna
First Received: August 23, 2006 Last Updated: October 2, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lupus Erythematosus, Systemic
Lupus Nephritis
Additional conditions recognized in this trial
Nephritis
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Glomerulonephritis
Immune System Diseases
Kidney Diseases
Urologic Diseases
Interventions listed in this trial
infliximab
placebo
Additional drug interventions recognized in this trial
Azathioprine
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antirheumatic Agents
Dermatologic Agents
Gastrointestinal Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Medical University of Vienna
Hospital Hietzing
Medical University of Graz
Charite University, Berlin, Germany
University of Erlangen-Nürnberg
Heinrich-Heine University, Duesseldorf
University Medical Centre Groningen
Leiden University Medical Center
Radboud University
Back to top of Main Content
